Michael P Dube
NTLAMichael P Dube serves as VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Michael P Dube's Insider Trading at Intellia Therapeutics, Inc. (NTLA)
Buys
0 · $0.00
Sells
5 · $139.9K
Total Shares Bought
0
Total Shares Sold
10,747
Related Insiders
BASTA JAMES
officer: EVP, General Counsel
NTLASell · Mar 3, 2026
Eliana Clark
officer: EVP, Chief Technical Officer
NTLASell · Mar 3, 2026
Edward J Dulac III
EVP, Chief Financial Officer
NTLASell · Jan 5, 2026
Birgit C Schultes
EVP, Chief Scientific Officer
NTLASell · Jan 5, 2026
Fred E Cohen
Director
NTLABuy · Jan 5, 2026
David Lebwohl
EVP, Chief Medical Officer
NTLASell · Jan 5, 2026
LEONARD JOHN M
President and CEO
NTLASell · Jan 5, 2026
CHASE WILLIAM J
Director
NTLABuy · Aug 20, 2025